Condition
Melanocytic Nevi
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07428941Completed
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
NCT07277920RecruitingPrimary
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
NCT03054584RecruitingPrimary
Genetic Basis of Melanocytic Nevi
NCT00339222Completed
Family Study of Melanoma in Italy
NCT00288938CompletedPrimary
Natural History Study of Moles and Suspicious Melanoma
Showing all 5 trials